Britain launches mass swine flu jab programme

Relax News
Wednesday 21 October 2009 00:00
Comments

Britain launched a mass vaccination programme to prevent the further spread of swine flu Wednesday, with officials urging healthcare workers and at-risk patients to be first in line.

The jab will be available to more than 11 million people deemed at highest risk from catching swine flu, who will be contacted by their doctors.

As well as health workers, those who it is suggested should take up the vaccination include all pregnant women, some over 65s and people who live with those who have weakened immune systems due to, for example, cancer treatment.

Patients will be vaccinated with Pandemrix, made by British drugmaker GlaxoSmithKline, which says it has received orders for 440 million doses ahead of the northern hemisphere's winter which could bring a second wave of the virus.

"This is the first pandemic for which we have had vaccine to protect people," said Liam Donaldson, the British government's top medical adviser.

"I urge everyone in the priority groups to have the vaccine -- it will help prevent people in clinical risk groups from getting swine flu and the complications that may arise from it."

Britain is also offering swine flu vaccinations to all its 9,000 troops in Afghanistan to protect them from a possible mass outbreak, the Ministry of Defence said last week.

Britain is the hardest hit country in Europe by the A(H1N1) virus. The number of Britons with the virus who have died has risen to 106, according to the latest figures, released last week.

kah/mt/ach

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in